Industrialization’s eye view on theranostic nanomedicine [PDF]
Frontiers in Chemistry, 2022 The emergence of nanomedicines (NMs) in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario.
Maharajan Sivasubramanian +4 more
doaj +4 more sources
Theranostic Nanomedicine for Malignant Gliomas [PDF]
Frontiers in Bioengineering and Biotechnology, 2019 Brain tumors mainly originate from glial cells and are classified as gliomas. Malignant gliomas represent an incurable disease; indeed, after surgery and chemotherapy, recurrence appears within a few months, and mortality has remained high in the last ...
Michele d'Angelo +9 more
doaj +6 more sources
Editorial: Advanced Theranostic Nanomedicine in Oncology [PDF]
Frontiers in Bioengineering and Biotechnology, 2020 The Research Topic entitled “Advanced Theranostic Nanomedicine in Oncology” presents a series of articles that describe the latest research updates of biologically-inspired nanostructures used in the field of oncology. In addition, it briefly describes the biological mechanisms of certain cancers and how we can take advantage of these mechanisms to ...
Christos Tapeinos +2 more
doaj +8 more sources
Theranostic nanomedicine: Potential therapeutic epitome
Journal of Advanced Pharmaceutical Technology & Research, 2015 Upendra Nagaich
doaj +4 more sources
Corrigendum: Theranostic Nanomedicine for Malignant Gliomas [PDF]
Frontiers in Bioengineering and Biotechnology, 2020 [This corrects the article DOI: 10.3389/fbioe.2019.00325.].
Michele d'Angelo +9 more
doaj +5 more sources
Advancements and Perspectives in Polysaccharide-Based Nanoparticles for Theranostic Nanomedicine [PDF]
Pharmaceuticals, 2023 It is with great enthusiasm [...]
Jingdi Chen
doaj +2 more sources
Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform [PDF]
Materials Today Bio, 2023 Exosomes have emerged as a promising cell-free therapeutic approach. However, challenges in large-scale production, quality control, and heterogeneity must be overcome before they can be used clinically.
Xiao Xu +5 more
doaj +2 more sources
Design of Experiments Leads to Scalable Analgesic Near-Infrared Fluorescent Coconut Nanoemulsions [PDF]
PharmaceuticsBackground: Pain is a complex phenomenon characterized by unpleasant experiences with profound heterogeneity influenced by biological, psychological, and social factors. According to the National Health Interview Survey, 50.2 million U.S.
Amit Chandra Das +6 more
doaj +2 more sources
Harnessing nanomedicine to target NF-κB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation [PDF]
Cell Communication and SignalingThe nuclear factor kappa B (NF-κB) signalling pathway is a pivotal orchestrator of inflammation, tumour progression, immune modulation, and metabolic reprogramming within the dynamic landscape of the tumour microenvironment (TME).
Bandari BharathwajChetty +7 more
doaj +2 more sources
Pharmaceuticals, 2022 Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic diseases in the 21st century, with a high mortality rate. This review summarizes the various nanomedicines for diagnostic and therapeutic applications in CVRDs, including ...
Natasha Manners +9 more
doaj +1 more source